Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Noncarious Cervical Lesions: later-stage trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Noncarious Cervical Lesions: 1 US clinical trial tracked, none currently recruiting.

Noncarious Cervical Lesions is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Pearl Network, running 1 of these trials.

Enrollment posture brief

Registry condition noncarious-cervical-lesions

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Noncarious Cervical Lesi (th…0%
Open-enrollment share among volume-matched conditions near Noncarious Cervical Lesions

Noncarious Cervical Lesions has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Noncarious Cervical Lesions on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Noncarious Cervical Lesions is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Pearl Network 1 trials

Named interventions

Most-linked intervention names on Noncarious Cervical Lesions records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Clearfil S3 Bond; Premise Flowable resin-based composite Other
1 trials
Clearfil S3 Bond; Clearfil Liner Bond 2 Protect Liner F Other
1 trials
Chemoactive (remineralizing, neuroactive) dentifrice treatment Other
1 trials

US sites by state

Facility locations filed on Noncarious Cervical Lesions trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials
Ohio 1 trials
New York 1 trials
New Jersey 1 trials
Maryland 1 trials
Massachusetts 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Noncarious Cervical Lesions page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Noncarious Cervical Lesions trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Pearl Network sponsors the most Noncarious Cervical Lesions trials on record, review their full trial history before evaluating a specific study. See Pearl Network's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Noncarious Cervical Lesions condition card totals 1 registered trials; most-linked intervention Clearfil S3 Bond; Premise Flowable resin-based composite; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.